RT @GrupoPKgen_SEFH: #TherapeuticDrugMonitoring of biopharmaceuticals to #InflammatoryDiseases: a valuable tool for (cost-effective) treatm…
RT @GrupoPKgen_SEFH: #TherapeuticDrugMonitoring of biopharmaceuticals to #InflammatoryDiseases: a valuable tool for (cost-effective) treatm…
RT @GrupoPKgen_SEFH: #TherapeuticDrugMonitoring of biopharmaceuticals to #InflammatoryDiseases: a valuable tool for (cost-effective) treatm…
RT @GrupoPKgen_SEFH: #TherapeuticDrugMonitoring of biopharmaceuticals to #InflammatoryDiseases: a valuable tool for (cost-effective) treatm…
RT @GrupoPKgen_SEFH: #TherapeuticDrugMonitoring of biopharmaceuticals to #InflammatoryDiseases: a valuable tool for (cost-effective) treatm…
RT @GrupoPKgen_SEFH: #TherapeuticDrugMonitoring of biopharmaceuticals to #InflammatoryDiseases: a valuable tool for (cost-effective) treatm…
#TherapeuticDrugMonitoring of biopharmaceuticals to #InflammatoryDiseases: a valuable tool for (cost-effective) treatment optimization and a clinical decision-support tool in combination with follow-up of clinical performance #pharmacokinetic target="_blank" href="https://t.co/">https://t.co/
Recommendations for TDM of biopharmaceuticals in inflammatory diseases thanx to @LeStudium @UnivTours @DovePress https://t.co/vOvwem5zox https://t.co/DxU5gIBTp1